Bill Wexler's Trading Cabana Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Trading Cabana

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RockyBalboa who wrote (5505)	5/18/2009 12:05:55 PM
From: Kevin Podsiadlik	Read Replies (1) of 6370

only to fall to pennies later as the approval didnt make then any money. I very strongly doubt Ampligen would get ignored after approval. CFS is one of those contentious things with very inconsistent symptoms, leading some to doubt its legitimacy as a condition, leading others to be very anxious to prove its legitimacy, leading them to be very likely to latch hard on to an FDA approval of a CFS treatment as said proof. Oh, and there is a little something news-ish behind today. Apparently swine flu is still an epidemic in Osaka, and, by coincidence, Ampligen is just starting to undergo human trials in Japan as potentially having something to do about it. (It's all a little vague and seemingly a long way from substance, but hype is hype.)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next